Jøntvedt Jørgensen, M., Nore, K. G., Aass, H. C. D., Layre, E., Nigou, J., Mortensen, R., . . . Dyrhol-Riise, A. M. (2021). Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients. Front Cell Infect Microbiol.
Dyfyniad Arddull ChicagoJøntvedt Jørgensen, Marthe, et al. "Plasma LOX-Products and Monocyte Signaling Is Reduced By Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients." Front Cell Infect Microbiol 2021.
Dyfyniad MLAJøntvedt Jørgensen, Marthe, et al. "Plasma LOX-Products and Monocyte Signaling Is Reduced By Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients." Front Cell Infect Microbiol 2021.